Proceedings of the 4th International Conference on Law, Social Sciences, Economics, and Education, ICLSSEE 2024, 25 May 2024, Jakarta, Indonesia

Research Article

Legal Analysis of Patient Rights in The Context of Developing Genetic Technology for Human Health

Download65 downloads
  • @INPROCEEDINGS{10.4108/eai.25-5-2024.2349380,
        author={Ineke Winda Ferianasari and Suparno  Suparno},
        title={Legal Analysis of Patient Rights in The Context of Developing Genetic Technology for Human Health},
        proceedings={Proceedings of the 4th International Conference on Law, Social Sciences, Economics, and Education, ICLSSEE 2024, 25 May 2024, Jakarta, Indonesia},
        publisher={EAI},
        proceedings_a={ICLSSEE},
        year={2024},
        month={8},
        keywords={health law genetic technology patient rights},
        doi={10.4108/eai.25-5-2024.2349380}
    }
    
  • Ineke Winda Ferianasari
    Suparno Suparno
    Year: 2024
    Legal Analysis of Patient Rights in The Context of Developing Genetic Technology for Human Health
    ICLSSEE
    EAI
    DOI: 10.4108/eai.25-5-2024.2349380
Ineke Winda Ferianasari1,*, Suparno Suparno1
  • 1: Universitas Borobudur
*Contact email: inekewfs@gmail.com

Abstract

In the context of rapid advances in genetic technologies for human healthcare, it is important to analyze the legal framework governing the rights of patients. Previous research underscores the need to enhance protection of these rights, but gaps remain in the literature. This study aims to explore key aspects of the existing legal framework affecting patients' rights in the development and application of genetic technologies. The research will evaluate the extent to which the existing legal framework protects patient rights and identify legal gaps that may need to be addressed. The results of this study indicate the need for more specific legal guidelines to govern the use of genetic technologies for human health and the importance of cooperation between government, industry, and civil society to protect patients' rights in healthcare processes involving genetic technology.